PMV Pharmaceuticals, Inc.

NasdaqGS:PMVP 株式レポート

時価総額:US$76.2m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

PMV Pharmaceuticals マネジメント

マネジメント 基準チェック /34

PMV Pharmaceuticals'の CEO はDavid Mackで、 Jul2013年に任命され、 の在任期間は 10.92年です。 の年間総報酬は$ 2.21Mで、 26.5%給与と73.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の1.26%を直接所有しており、その価値は$ 1.07M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と3.9年です。

主要情報

David Mack

最高経営責任者

US$2.2m

報酬総額

CEO給与比率26.5%
CEO在任期間11.3yrs
CEOの所有権1.3%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans?

Aug 04
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans?

Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Apr 20
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Dec 22
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth

Sep 08
We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans

Jan 11
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans

Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Sep 22
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

PMV Pharmaceuticals GAAP EPS of -$0.38 beats by $0.04

Aug 09

PMV Pharma joins Merck to study lead candidate with Keytruda

Jul 18

Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Jun 09
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

Feb 23
Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Nov 05
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

Jul 23
Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation

PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Strong Position To Grow Its Business

Apr 09
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Strong Position To Grow Its Business

Do Institutions Own PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares?

Dec 25
Do Institutions Own PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares?

PMV Pharmaceuticals reports Q3 results

Nov 13

CEO報酬分析

PMV Pharmaceuticals の収益と比較して、David Mack の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$49m

Mar 31 2024n/an/a

-US$65m

Dec 31 2023US$2mUS$586k

-US$69m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$74m

Dec 31 2022US$4mUS$564k

-US$73m

Sep 30 2022n/an/a

-US$72m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$65m

Dec 31 2021US$4mUS$545k

-US$58m

Sep 30 2021n/an/a

-US$50m

Jun 30 2021n/an/a

-US$44m

Mar 31 2021n/an/a

-US$39m

Dec 31 2020US$1mUS$495k

-US$34m

Sep 30 2020n/an/a

-US$31m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$27m

Dec 31 2019US$628kUS$461k

-US$25m

報酬と市場: Davidの 総報酬 ($USD 2.21M ) は、 US市場 ($USD 678.50K ) の同規模の企業の平均を上回っています。

報酬と収益: Davidの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

David Mack (62 yo)

11.3yrs

在職期間

US$2,209,795

報酬

Dr. David H. Mack, Ph D., Co-founded PMV Pharmaceuticals, Inc. in 2013 and also serves as its President and Chief Executive Officer since July 2013. Dr. Mack joined the PMV Pharmaceuticals, Inc. in 2013.D...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
David Mack
Co-Founder11.3yrsUS$2.21m1.26%
$ 960.2k
Arnold Levine
Co-Founder11.8yrsUS$220.27k0.80%
$ 606.6k
Deepika Jalota
Chief Development Officer5.3yrsUS$1.10m0.044%
$ 33.6k
Michael Carulli
Chief Financial Officerless than a yearデータなし0.012%
$ 9.1k
Robert Ticktin
General Counsel4.2yrsデータなしデータなし
Tim Smith
Senior VP and Head of Corporate Development & Investor Relations3.1yrsデータなしデータなし
Crystal Zuckerman
Vice President of Human Resources1.8yrsデータなしデータなし
Binh Vu
Senior Vice President of Drug Discovery & CMCno dataデータなしデータなし
Marc Fellous
Senior VP and Head of Clinical Development & Medical Affairs1.4yrsデータなしデータなし
Laura De Leon
VP & Head of Clinical Operationsno dataデータなしデータなし

3.6yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: PMVPの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
David Mack
Co-Founder11.3yrsUS$2.21m1.26%
$ 960.2k
Arnold Levine
Co-Founder11.3yrsUS$220.27k0.80%
$ 606.6k
Charles Sawyers
Member of Clinical Advisory Boardno dataデータなしデータなし
Carol Gallagher
Independent Director1.9yrsUS$124.27kデータなし
Richard Heyman
Independent Chairman of the Board of Directors & Member of Scientific Advisory Board4.3yrsUS$176.77k0%
$ 0
Scott Lowe
Chairman of Scientific Advisory Boardless than a yearデータなしデータなし
Charles Baum
Independent Director & Chair of Clinical Advisory Board3.5yrsUS$133.27k0%
$ 0
Laurie Stelzer
Independent Director4.2yrsUS$140.27k0%
$ 0
Kirsten Flowers
Independent Director2.8yrsUS$127.77k0%
$ 0
Guillermina Lozano
Member of Scientific Advisory Board3.7yrsデータなしデータなし

3.7yrs

平均在職期間

63.5yo

平均年齢

経験豊富なボード: PMVPの 取締役会経験豊富 であると考えられます ( 3.9年の平均在任期間)。